Articles dans des revues avec comité de lecture (54)

  1. 37. Boom, A., Authelet, M., Dedecker, R., Frédérick, C., Van Heurck, R., Daubie, V., Leroy, K., Pochet, R., & Brion, J. P. (2009). Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells. Biochimica et biophysica acta, 1793(6), 1058-1067. doi:10.1016/j.bbamcr.2008.11.011
  2. 38. Langer, I., Leroy, K., Gaspard, N., Brion, J. P., & Robberecht, P. (2008). Cell surface targeting of VPAC1 receptors: evidence for implication of a quality control system and the proteasome. Biochimica et biophysica acta, 1783(9), 1663-1672. doi:10.1016/j.bbamcr.2008.03.013
  3. 39. Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J. P. (2007). Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. The American journal of pathology, 171(3), 976-992. doi:10.2353/ajpath.2007.070345
  4. 40. Leroy, K., Yilmaz, Z., & Brion, J. P. (2007). Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathology and applied neurobiology, 33(1), 43-55. doi:10.1111/j.1365-2990.2006.00795.x
  5. 41. Schindowski, K., Bretteville, A., Leroy, K., Bégard, S., Brion, J. P., Hamdane, M., & Buée, L. (2006). Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. The American journal of pathology, 169(2), 599-616. doi:10.2353/ajpath.2006.060002
  6. 42. Feyt, C., Kienlen-Campard, P. K., Leroy, K., N'Kuli, F., Courtoy, P., Brion, J. P., & Octave, J. N. (2005). Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3. The Journal of biological chemistry, 280(39), 33220-33227. doi:10.1074/jbc.M501610200
  7. 43. Derkinderen, P., Scales, T. M. E., Hanger, D., Leung, K.-Y., Byers, H. L., Ward, M. A., Lenz, C., Price, C., Bird, I. N., Perera, T., Kellie, S., Williamson, R., Noble, W., Van Etten, R. A., Leroy, K., Brion, J. P., Reynolds, C. H., & Anderton, B. (2005). Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. The Journal of neuroscience, 25(28), 6584-6593. doi:10.1523/JNEUROSCI.1487-05.2005
  8. 44. Boutajangout, A., Boom, A., Leroy, K., & Brion, J. P. (2004). Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. FEBS letters, 576(1-2), 183-189. doi:10.1016/j.febslet.2004.09.011
  9. 45. Leroy, K., Boutajangout, A., Richardson, J. C., Octave, J. N., Lovestone, S., Anderton, B., & Brion, J. P. (2003). Mutant presenilin 1 proteins induce cell death and reduce tau-dependent processes outgrowth. Neuroscience letters, 353(3), 226-230. doi:10.1016/j.neulet.2003.09.051
  10. 46. Leroy, K., Boutajangout, A., Authelet, M., Woodgett, J. R., Anderton, B., & Brion, J. P. (2002). The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathologica, 103(2), 91-99. doi:10.1007/s004010100435
  11. 47. Boutajangout, A., Leroy, K., Touchet, N., Authelet, M., Blanchard, V., Tremp, G., Pradier, L., & Brion, J. P. (2002). Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1. Neuroscience letters, 318(1), 29-33. doi:10.1016/S0304-3940(01)02461-2
  12. 48. Leroy, K., Duyckaerts, C., Bovekamp, L., Müller, O., Anderton, B., & Brion, J. P. (2001). Increase of adenomatous polyposis coli immunoreactivity is a marker of reactive astrocytes in Alzheimer's disease and in other pathological conditions. Acta Neuropathologica, 102(1), 1-10.

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>